International agreement to eliminate customs duties on approved pharmaceuticals

EU Member States adopted an international agreement to eliminate customs dutieson all new pharmaceuticals traded with the US and Switzerland. The agreement wasreached on 12 January 2007 and eliminates customs duties between the EU,Switzerland and US on finished pharmaceutical products and on the chemicalintermediates used in their production. It replaces a previous agreement from1994 that already enabled many pharmaceuticals to benefit from zero-tariffs, butdid not cover any of the more recent products. With this review, 1,290additional products have been added to the 7,329 products currently benefitingfrom duty-free treatment. The EU imports more than 80% of its pharmaceuticalsfrom the US and Switzerland, and the European Chemical Industry Council (CEFIC)believes that the agreement could save European pharmaceutical companies up to€230 million in 2007 alone.
Other articles
KŠB Confirms Its Position in the Chambers Global Guide 2026
In the latest edition of the prestigious Chambers Global Guide 2026, KŠB once again reaffirms its strong position among the leading law firms on the Czech market. Recognition across all four ranked practice areas confirms the stability of our teams and the long-term trust of our clients.
KŠB na společném fóru soudců a advokátů
Dne 12. února 2026 se v Brně uskutečnil 2. ročník společného setkání zástupců ze soudnictví a advokacie pod záštitou České advokátní komory a Nejvyššího správního soudu. Naši advokátní kancelář na tomto významném fóru zastupovali Petra Mirovská a Jakub Mehl.
KŠB Advises J&T Banka, UniCredit and PPF banka on the Next Phase of EMMA Capital’s Bond Programme
KŠB has continued its legal advisory role in connection with investment group EMMA Capital’s bond programme, which has been generating sustained and strong investor interest.